WebMay 24, 2024 · Background Cisplatin (DDP) is a major chemotherapeutic drug which was widely used for cervical cancer (CC) patients with advanced or recurrent although its limitation in the development of resistance. LncRNA nicotinamide nucleotide transhydrogenase-antisense RNA1 (NNT-AS1) has been reported to be involved in the … WebJan 27, 2024 · those divergent genes may overlap (e.g., RNF157-AS1 andFOXJ1 ,FOXC2-AS1 FOXC2 ZCCHC14-DT and ZCCHC14). In other cases, like lncRNA gene FENDRR …
LncRNA NNT-AS1 contributes to the cisplatin resistance of …
WebCROSS-REFERENCE TO RELATED APPLICATIONS. This application is a Continuation of U.S. patent application Ser. No. 16/649,732, filed Mar. 23, 2024, which is a national stage filing u WebAug 15, 2024 · To test our hypothesis, CCK8 assay suggested overexpression of RNF157-AS1 significantly decreased the chemoresistance to cisplatin (DDP) and silencing of … flights from hay river airport
Identification of Three Prognosis-Related Differentially Expressed ...
WebFeb 20, 2024 · Analyses of several databases showed that the lncRNA RNF157 Antisense RNA 1 (RNF157-AS1) is overexpressed in epithelial ovarian cancer (EOC) tissues. In our … WebNov 10, 2024 · Conclusion: RNF157-AS1 may be involved in doxorubicin resistance and may serve as a potential therapeutic target. The four-gene risk model showed potential for the … Web1.2259999999999999e-38 5.3959999999999996e-35 5.3959999999999996e-35 4.8380000000000003e-34 475 1360. 8.9970000000000004e-24 2.3759999999999999e-19 2.3759999999999999e-19 cheri lindberg brainspotting